APA (NASDAQ:APA – Get Free Report) had its price target decreased by equities researchers at Susquehanna from $31.00 to $30.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “positive” rating on the stock. Susquehanna’s price target would suggest a potential upside of 88.87% from the stock’s previous close.
Several other research firms have also weighed in on APA. JPMorgan Chase & Co. lowered their price objective on shares of APA from $23.00 to $20.00 and set a “neutral” rating for the company in a research note on Thursday, March 13th. Raymond James downgraded shares of APA from a “strong-buy” rating to an “outperform” rating and reduced their price target for the company from $45.00 to $32.00 in a research report on Monday, March 10th. Morgan Stanley set a $20.00 price objective on shares of APA and gave the stock an “underweight” rating in a report on Tuesday, April 15th. Royal Bank of Canada decreased their price objective on APA from $27.00 to $24.00 and set a “sector perform” rating for the company in a report on Friday, April 11th. Finally, Barclays decreased their price objective on shares of APA from $27.00 to $25.00 and set an “equal weight” rating for the company in a research note on Tuesday, March 18th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, APA currently has a consensus rating of “Hold” and a consensus price target of $26.16.
Check Out Our Latest Stock Analysis on APA
APA Price Performance
APA (NASDAQ:APA – Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.79 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.97 by ($0.18). The firm had revenue of $2.50 billion during the quarter, compared to analyst estimates of $2.31 billion. APA had a net margin of 24.36% and a return on equity of 27.86%. Equities research analysts forecast that APA will post 4.03 earnings per share for the current fiscal year.
Hedge Funds Weigh In On APA
Institutional investors have recently added to or reduced their stakes in the business. ProShare Advisors LLC grew its position in APA by 0.4% during the fourth quarter. ProShare Advisors LLC now owns 113,913 shares of the company’s stock valued at $2,630,000 after acquiring an additional 449 shares during the last quarter. Van ECK Associates Corp boosted its holdings in APA by 0.6% in the fourth quarter. Van ECK Associates Corp now owns 77,110 shares of the company’s stock valued at $1,780,000 after acquiring an additional 469 shares in the last quarter. Nissay Asset Management Corp Japan ADV boosted its stake in shares of APA by 1.1% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 46,063 shares of the company’s stock valued at $1,018,000 after purchasing an additional 517 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in shares of APA by 0.4% during the 4th quarter. Asset Management One Co. Ltd. now owns 138,991 shares of the company’s stock worth $3,070,000 after acquiring an additional 544 shares during the period. Finally, Segment Wealth Management LLC raised its holdings in APA by 1.1% in the fourth quarter. Segment Wealth Management LLC now owns 54,938 shares of the company’s stock worth $1,269,000 after purchasing an additional 571 shares in the last quarter. 83.01% of the stock is currently owned by institutional investors.
APA Company Profile
APA Corporation, an independent energy company, explores for, develops, and produces natural gas, crude oil, and natural gas liquids. It has oil and gas operations in the United States, Egypt, and North Sea. The company also has exploration and appraisal activities in Suriname, as well as holds interests in projects located in Uruguay and internationally.
Further Reading
- Five stocks we like better than APA
- What is the NASDAQ Stock Exchange?
- 4 Stocks With +3% Yields and 50+ Years of Dividend Increases
- Top Biotech Stocks: Exploring Innovation Opportunities
- Medtronic: A Dividend Aristocrat With Stability and Innovation
- Are Penny Stocks a Good Fit for Your Portfolio?
- Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
Receive News & Ratings for APA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for APA and related companies with MarketBeat.com's FREE daily email newsletter.